Analysis

Viatris Inc. (VTRS) Stock Analysis

Viatris Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to VTRS.

websiteVTRS/analysis/VTRS

Viatris Inc.

Viatris Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to VTRS.

Stock profile

Ticker

VTRS

Asset type

Stock

Market cap

$19.19B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Viatris Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • VTRS primary listing
  • VIA
  • 1VTRS
  • A2QAME
  • 4VTRS
  • 0A5V
  • VTRS.USD
  • VTRSN

Latest Viatris Inc. news

Viatris Recognized as One of the 2026 Best Workplaces™ in Canada

Viatris Inc. (Nasdaq: VTRS) has been recognized as one of the 2026 Best Workplaces™ in Canada by Great Place to Work®. This recognition highlights Viatris' commitment to fosteri...

U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA)...

Viatris to Present at the Bank of America Securities 2026 Healthcare Conference

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will present at the Bank of America Securities 2026 Healthcare Conference on Tuesday, ...

Viatris Announces Chief Financial Officer Transition

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Theodora "Doretta" Mistras, Chief Financial Officer, will depart the Company for a new professiona...

Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck...

The chlorpheniramine maleate market is poised for growth due to rising allergic conditions, OTC antihistamine awareness, and pharmaceutical innovationDublin, May 01, 2026 (GLOBE...

Research sections

Valuation

Review valuation context for Viatris Inc..

Future growth

Review future growth context for Viatris Inc..

Past performance

Review past performance context for Viatris Inc..

Financial health

Review financial health context for Viatris Inc..

Dividend

Review dividend context for Viatris Inc..

Management

Review management context for Viatris Inc..

Ownership

Review ownership context for Viatris Inc..

Other information

Review other information context for Viatris Inc..

Community

Review community context for Viatris Inc..